ORPI FRANCE – Trademark Portfolio
Entity Type: 99
ORPI FRANCE holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 7 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ORPI.
20 Rue Charles Paradinas
F-92110 CLICHY
Showing of trademarks Trademarks
Trademark Classifications
ORPI FRANCE's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Education; providing of training; entertainment; sporting and cultural activities
Legal services; security services for the protection of property and individuals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does ORPI FRANCE have?
ORPI FRANCE has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does ORPI FRANCE file in?
ORPI FRANCE files trademarks across 7 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 45 (Legal & Security Services), Class 37 (Building & Construction), Class 38 (Telecommunications). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are ORPI FRANCE's most well-known trademarks?
ORPI FRANCE's registered trademark portfolio includes well-known marks such as ORPI. These are among 1 currently registered trademark in the portfolio.
What is ORPI FRANCE's trademark registration success rate?
ORPI FRANCE has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.